Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
19.07 USD | -1.04% | -2.77% | -9.99% |
Apr. 16 | Leerink Partners Starts AnaptysBio With Outperform Rating, $47 Price Target | MT |
Apr. 11 | Wells Fargo Initiates AnaptysBio With Overweight Rating, $56 Price Target | MT |
- Stock Market
- Equities
- ANAB Stock
- News AnaptysBio, Inc.